Glaxosmithkline Pharmaceuticals informs about disclosure

28 Oct 2023 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the Company has received a Notice from Kerala State GST authorities, seeking to disallow transitional Excise duty credit (TRAN 1 credit) claimed in Kerala State. Relevant details are enclosed. Since this issue in procedural in nature, the Company is settling the issue basis internal assessment. There is a penalty of Rs.40,635 which is also procedural in nature under Section 73 of GST Act and not specific to any suppression, willful misstatement done by the Company.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2380.90 3.25 (0.14%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×